111, Inc. (YI)
USD 0.77
(-1.16%)
USD 0.77
(-1.16%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 443.22 Million CNY | 58.6% |
| 2022 | 279.45 Million CNY | -34.29% |
| 2021 | 425.27 Million CNY | 45.82% |
| 2020 | 291.63 Million CNY | 91.75% |
| 2019 | 152.09 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 245.53 Million CNY | -6.16% |
| 2024 Q1 | 261.66 Million CNY | -40.96% |
| 2023 Q3 | 414.16 Million CNY | 3.97% |
| 2023 FY | 443.22 Million CNY | 58.6% |
| 2023 Q1 | 355.76 Million CNY | 27.31% |
| 2023 Q4 | 443.22 Million CNY | 7.02% |
| 2023 Q2 | 398.33 Million CNY | 11.96% |
| 2022 Q1 | 412.23 Million CNY | -3.07% |
| 2022 Q4 | 279.45 Million CNY | -18.92% |
| 2022 FY | 279.45 Million CNY | -34.29% |
| 2022 Q2 | 387.78 Million CNY | -5.93% |
| 2022 Q3 | 344.66 Million CNY | -11.12% |
| 2021 Q4 | 425.27 Million CNY | 56.31% |
| 2021 FY | 425.27 Million CNY | 45.82% |
| 2021 Q3 | 272.07 Million CNY | -3.72% |
| 2021 Q2 | 282.57 Million CNY | 64.63% |
| 2021 Q1 | 171.64 Million CNY | -41.15% |
| 2020 Q4 | 291.63 Million CNY | 26.23% |
| 2020 Q2 | 204.24 Million CNY | 103.2% |
| 2020 FY | 291.63 Million CNY | 91.75% |
| 2020 Q1 | 100.51 Million CNY | -33.91% |
| 2020 Q3 | 231.04 Million CNY | 13.12% |
| 2019 Q3 | 150.93 Million CNY | 95.6% |
| 2019 Q2 | 77.16 Million CNY | 27.65% |
| 2019 Q1 | 60.44 Million CNY | 0.0% |
| 2019 Q4 | 152.09 Million CNY | 0.77% |
| 2019 FY | 152.09 Million CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 1.32 Million USD | -33476.199% |
| BIMI International Medical Inc. | 5.45 Million USD | -8024.679% |
| China Jo-Jo Drugstores, Inc. | 43.21 Million USD | -925.519% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 190.5 Million USD | -132.664% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | -141.974% |
| Leafly Holdings, Inc. | 29.08 Million USD | -1423.909% |
| Leafly Holdings, Inc. | 29.08 Million USD | -1423.909% |
| LifeMD, Inc. | 18.93 Million USD | -2241.119% |
| LifeMD, Inc. | 18.93 Million USD | -2241.119% |
| TRxADE HEALTH, Inc. | 7.1 Million USD | -6139.226% |
| PetMed Express, Inc. | 1.45 Million USD | -30383.425% |
| Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 95.361% |